BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

MDxHealth, Inc. 

15279 Alton Parkway
Suite 100
Irvine  California  92618  U.S.A.
Phone: 949-812-6979 Fax: 949-242-2960


SEARCH JOBS




Industry
Diagnostics






 Company News
MDxHealth, Inc. (MXDHF) And LI PATH Announce Marketing Agreement For Confirmmdx For Prostate Cancer 4/2/2014 9:41:03 AM    More...
MDxHealth, Inc. (MXDHF)'s Predictmdx For Glioblastoma Identifies Newly Diagnosed Patients With Improved Progression Free And Overall Survival 3/4/2014 9:09:52 AM    More...
MDxHealth, Inc. (MXDHF) Reports Fourth Quarter And Fiscal Year 2013 Results 2/27/2014 9:27:13 AM    More...
MDxHealth, Inc. (MXDHF) Secures Agreement With Prime Health Services PPO Network Providing Increased Access To Confirmmdx For Prostate Cancer 2/20/2014 9:11:31 AM    More...
MDxHealth, Inc. (MXDHF)'s Confirmmdx® For Prostate Cancer Epigenetic Test Correctly Identifies Prostate Cancer Missed In Five Previous Biopsies 2/12/2014 9:10:57 AM    More...
MDxHealth, Inc. (MXDHF)'s ConfirmMDx Genes Identify Aggressive Prostate Cancer 2/3/2014 9:05:55 AM    More...
MDxHealth, Inc. (MXDHF)To Present Results From Epigenetic Prostate Test To Identify Aggressive Prostate Cancer At The American Society of Clinical Oncology Genitourinary Cancers Symposium 2014 1/29/2014 9:01:19 AM    More...
MDxHealth, Inc. (MXDHF) Announces Agreement With Teva Pharmaceutical Industries Limited (TEVA) For Commercialization Of Two Cancer Tests In Israel 1/23/2014 9:41:32 AM    More...
MDxHealth, Inc. (MXDHF) Secures Coverage For Prostate Cancer Test With Two Additional Insurance Companies 12/2/2013 9:53:05 AM    More...
MDxHealth, Inc. (MXDHF)'s MGMT Test Included in NCCN Guidelines and Awarded Tier 1 Reimbursement Code by American Medical Association 10/16/2013 10:00:34 AM    More...
12345